Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015661

Options or other derivatives

  • Director acquired 38,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

George Robert E. · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-06-20 Grant or award : show line 1 in the form Stock option (right to buy) +23,333 50,001 D
2022-06-20 Grant or award : show line 2 in the form Stock option (right to buy) +15,000 65,001 D
Loading xslF345X03/rdgdoc.xml…